NSE: TIRUMALCHM
THIRUMALAI CHEMICALS LTD
Price history
-4.49% over 3M
Performance
52-week range
Position in day range
TIRUMALCHM stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Downtrend
50-DMA ₹163.81
RSI (14)
37
Neutral momentum
Volatility (ATR)
3.69%
Moderate
Close streak
3d down
Volume vs 20d avg
0.65x
From 52W high
-52.10%
Up from 52W low
+9.76%
Green days (20)
6/20
Monthly seasonality
Average monthly move for TIRUMALCHM across the available price history.
Key statistics
Open
157.52
Day high
157.7
Day low
153.55
Prev close
157.5
Volume
4.32 L
Avg vol (20d)
6.60 L
52W high
328.8
52W low
143.5
TIRUMALCHM quarterly results
All TIRUMALCHM results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹547 cr
+21.5% YoY
Net profit
-₹43.67 cr
+27.2% YoY
Operating profit
₹9.58 cr
+119.8% YoY
EPS
₹-3.62
+38.2% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹547 cr | ₹9.58 cr | -₹43.67 cr | 1.8% | -8.0% | ₹-3.62 | +27.2% | -56.0% |
| Q4 FY262026-03-31 | ₹424 cr | -₹15.11 cr | -₹28 cr | -3.6% | -6.6% | ₹-2.32 | — | +39.9% |
| Q3 FY262025-12-31 | ₹416 cr | -₹37.74 cr | -₹46.57 cr | -9.1% | -11.2% | ₹-3.92 | — | -39.5% |
| Q2 FY262025-09-30 | ₹445 cr | -₹26.44 cr | -₹33.38 cr | -5.9% | -7.5% | ₹-3.07 | — | +44.3% |
| Q1 FY262025-06-30 | ₹450 cr | -₹48.38 cr | -₹59.96 cr | -10.7% | -13.3% | ₹-5.86 | — | — |
| TTM (last 4 quarters) | ₹1,832 cr | -₹69.71 cr | -₹152 cr | -3.8% | -8.3% | ₹-12.93 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
No stories tagged with TIRUMALCHM yet — see the latest from the markets desk below.
Latest market news
Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next
Jubilant Pharmova (JUBLPHARMA) trades at ₹1,025.20, -0.45 (-0.04%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
HDFC AMC Edges Lower to ₹2,403.90 — Should Investors Read This as a Trend or a One-Day Move?
HDFC AMC (HDFCAMC) trades at ₹2,403.90, -29.90 (-1.24%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.